Endometriosis

Editor’s note: This article was originally published in May 2024. Some time references have been adjusted for clarity. “Endometriosis made me want to jump off a building,” Tiffany Haddish admits candidly, revealing the extent of her chronic pain. For Haddish, cannabis has been a...

As the therapeutic potential of cannabis continues to garner attention, two recent studies have revealed its benefits in managing symptoms for those with endometriosis and reducing daytime fatigue in patients using CBD. Both studies, published in peer-reviewed journals, provide important insights...

The European Commission (EC) has approved Myovant Sciences Ltd's (NYSE: MYOV) Ryeqo (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) for the treatment of moderate to severe symptoms of uterine fibroids in adult women. The approval is based on safety and...

This article by Hugo Gray was originally published on The Green Fund, and appears here with permission. The condition currently affects approximately 11% of Australian women and could be costing the economy up to $4 billion per annum. There was big news earlier this week from Applied...

Benzinga recently had the chance to chat with Jason Napodano, biopharma analyst and consultant, owner of BioNap Consulting and former biotech analyst at Zacks. Below are just a few of the expert’s comments on potential M&A activity and partnerships in the biotech segment in the current...